Report Detail

Other Global Immune Cell Therapy Market Growth (Status and Outlook) 2022-2028

  • RnM4376356
  • |
  • 23 January, 2022
  • |
  • Global
  • |
  • 84 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

According to this study, the global Immune Cell Therapy market size will reach US$ million by 2028.

This report presents a comprehensive overview, market shares, and growth opportunities of Immune Cell Therapy market by product type, application, key players and key regions and countries.

Segmentation by product type:
T Cell Therapy
Natural Killer (NK) Cell Therapy
Other

Segmentation by Application:
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophageal Cancer
Pancreatic Cancer
Other

This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Immune Cell Therapy Market Size 2022-2028
    • 2.1.2 Immune Cell Therapy Market Size CAGR by Region
  • 2.2 Immune Cell Therapy Segment by Type
    • 2.2.1 T Cell Therapy
    • 2.2.2 Natural Killer (NK) Cell Therapy
    • 2.2.3 Other
  • 2.3 Immune Cell Therapy Market Size by Type
    • 2.3.1 Global Immune Cell Therapy Market Size Market Share by Type (2022-2028)
    • 2.3.2 Global Immune Cell Therapy Market Size Growth Rate by Type (2022-2028)
  • 2.4 Immune Cell Therapy Segment by Application
    • 2.4.1 Stomach Cancer
    • 2.4.2 Lung Cancer
    • 2.4.3 Colorectal Cancer
    • 2.4.4 Esophageal Cancer
    • 2.4.5 Pancreatic Cancer
    • 2.4.6 Other
  • 2.5 Immune Cell Therapy Market Size by Application
    • 2.5.1 Global Immune Cell Therapy Market Size Market Share by Application (2022-2028)
    • 2.5.2 Global Immune Cell Therapy Market Size Growth Rate by Application (2022-2028)

3 Immune Cell Therapy Key Players

  • 3.1 Date of Key Players Enter into Immune Cell Therapy
  • 3.2 Key Players Immune Cell Therapy Product Offered
  • 3.3 Key Players Immune Cell Therapy Funding/Investment Analysis
  • 3.4 Funding/Investment
    • 3.4.1 Funding/Investment by Regions
    • 3.4.2 Funding/Investment by End-Industry
  • 3.5 Key Players Immune Cell Therapy Valuation & Market Capitalization
  • 3.6 Key Players Mergers & Acquisitions, Expansion Plans
  • 3.7 Market Ranking
  • 3.8 New Product/Technology Launches
  • 3.9 Partnerships, Agreements, and Collaborations
  • 3.10 Mergers and Acquisitions

4 Immune Cell Therapy by Regions

  • 4.1 Immune Cell Therapy Market Size by Regions (2022-2028)
  • 4.2 United States Immune Cell Therapy Market Size Growth (2022-2028)
  • 4.3 China Immune Cell Therapy Market Size Growth (2022-2028)
  • 4.4 Europe Immune Cell Therapy Market Size Growth (2022-2028)
  • 4.5 Rest of World Immune Cell Therapy Market Size Growth (2022-2028)

5 United States

  • 5.1 United States Immune Cell Therapy Market Size by Type (2022-2028)
  • 5.2 United States Immune Cell Therapy Market Size by Application (2022-2028)

6 China

  • 6.1 China Immune Cell Therapy Market Size by Type (2022-2028)
  • 6.2 China Immune Cell Therapy Market Size by Application (2022-2028)

7 Europe

  • 7.1 Europe Immune Cell Therapy Market Size by Type (2022-2028)
  • 7.2 Europe Immune Cell Therapy Market Size by Application (2022-2028)

8 Rest of World

  • 8.1 Rest of World Immune Cell Therapy Market Size by Type (2022-2028)
  • 8.2 Rest of World Immune Cell Therapy Market Size by Application (2022-2028)
  • 8.3 Japan
  • 8.4 South Korea
  • 8.5 Southeast Asia

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Key Investors in Immune Cell Therapy

  • 10.1 Company A
    • 10.1.1 Company A Company Details
    • 10.1.2 Company Description
    • 10.1.3 Companies Invested by Company A
    • 10.1.4 Company A Key Development and Market Layout
  • 10.2 Company B
    • 10.2.1 Company B Company Details
    • 10.2.2 Company Description
    • 10.2.3 Companies Invested by Company B
    • 10.2.4 Company B Key Development and Market Layout
  • 10.3 Company C
    • 10.3.1 Company C Company Details
    • 10.3.2 Company Description
    • 10.3.3 Companies Invested by Company C
    • 10.3.4 Company C Key Development and Market Layout
  • 10.4 Company D
  • 10.5 ……

11 Key Players Analysis

  • 11.1 Adaptimmune
    • 11.1.1 Adaptimmune Company Details
    • 11.1.2 Adaptimmune Immune Cell Therapy Product Offered
    • 11.1.3 Adaptimmune Immune Cell Therapy Market Size (2022 VS 2027)
    • 11.1.4 Adaptimmune Main Business Overview
    • 11.1.5 Adaptimmune News
  • 11.2 Altor Bioscience Corporation
    • 11.2.1 Altor Bioscience Corporation Company Details
    • 11.2.2 Altor Bioscience Corporation Immune Cell Therapy Product Offered
    • 11.2.3 Altor Bioscience Corporation Immune Cell Therapy Market Size (2022 VS 2027)
    • 11.2.4 Altor Bioscience Corporation Main Business Overview
    • 11.2.5 Altor Bioscience Corporation News
  • 11.3 Cellectis
    • 11.3.1 Cellectis Company Details
    • 11.3.2 Cellectis Immune Cell Therapy Product Offered
    • 11.3.3 Cellectis Immune Cell Therapy Market Size (2022 VS 2027)
    • 11.3.4 Cellectis Main Business Overview
    • 11.3.5 Cellectis News
  • 11.4 Juno Therapeutics
    • 11.4.1 Juno Therapeutics Company Details
    • 11.4.2 Juno Therapeutics Immune Cell Therapy Product Offered
    • 11.4.3 Juno Therapeutics Immune Cell Therapy Market Size (2022 VS 2027)
    • 11.4.4 Juno Therapeutics Main Business Overview
    • 11.4.5 Juno Therapeutics News
  • 11.5 Kite Pharma
    • 11.5.1 Kite Pharma Company Details
    • 11.5.2 Kite Pharma Immune Cell Therapy Product Offered
    • 11.5.3 Kite Pharma Immune Cell Therapy Market Size (2022 VS 2027)
    • 11.5.4 Kite Pharma Main Business Overview
    • 11.5.5 Kite Pharma News
  • 11.6 Novartis
    • 11.6.1 Novartis Company Details
    • 11.6.2 Novartis Immune Cell Therapy Product Offered
    • 11.6.3 Novartis Immune Cell Therapy Market Size (2022 VS 2027)
    • 11.6.4 Novartis Main Business Overview
    • 11.6.5 Novartis News
  • 11.7 Takara Bio
    • 11.7.1 Takara Bio Company Details
    • 11.7.2 Takara Bio Immune Cell Therapy Product Offered
    • 11.7.3 Takara Bio Immune Cell Therapy Market Size (2022 VS 2027)
    • 11.7.4 Takara Bio Main Business Overview
    • 11.7.5 Takara Bio News
  • 11.8 Unum Therapeutics
    • 11.8.1 Unum Therapeutics Company Details
    • 11.8.2 Unum Therapeutics Immune Cell Therapy Product Offered
    • 11.8.3 Unum Therapeutics Immune Cell Therapy Market Size (2022 VS 2027)
    • 11.8.4 Unum Therapeutics Main Business Overview
    • 11.8.5 Unum Therapeutics News

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Immune Cell Therapy . Industry analysis & Market Report on Immune Cell Therapy is a syndicated market report, published as Global Immune Cell Therapy Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Immune Cell Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,898.72
5,797.44
3,389.16
6,778.32
553,941.00
1,107,882.00
305,244.00
610,488.00
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report